| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6099613 | Journal of Crohn's and Colitis | 2013 | 6 Pages |
Abstract
As a CD biomarker, serum calprotectin has a similar profile as hsCRP. It is also complementary to fecal calprotectin and hsCRP for prediction of relapse after infliximab withdrawal.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
M.-A. Meuwis, G. Vernier-Massouille, J.C. Grimaud, Y. Bouhnik, D. Laharie, E. Piver, L. Seidel, J.F. Colombel, E. Louis,